Urinary Tract Infection Diagnosis and Treatment

Diagnostic Criteria

• A urine culture with ≥50,000 CFU/mL of a single uropathogen is considered significant for infants and children, and ≥100,000 CFU/mL is significant for clean-catch/voided specimens, according to the American Academy of Pediatrics and other guidelines 1, 2
• The absence of pyuria suggests colonization rather than infection, and non-pathogenic organisms are not typically considered significant, as stated by the American Academy of Pediatrics 1
• The presence of pyuria is crucial for distinguishing true UTI from asymptomatic bacteriuria, with significant pyuria defined as ≥10 white blood cells/mm³ on "enhanced urinalysis", ≥5 white blood cells per high power field on centrifuged specimen, or any leukocyte esterase on dipstick, according to the IDSA guidelines 3, 1
• Test characteristics for UTI diagnosis are as follows:

4

Urinary Tract Infection Characteristics

• Pyuria is the hallmark of true UTI and helps distinguish it from asymptomatic bacteriuria, as reported by the American Academy of Family Physicians 5
• The host's inflammatory response, characterized by pyuria, is what results in scarring, according to the American Academy of Family Physicians 5
• UTIs are considered complicated if factors such as obstruction, foreign body presence, incomplete voiding, male gender, pregnancy, diabetes mellitus, immunosuppression, recent instrumentation, or healthcare-associated infection are present, as defined by the European Association of Urology 6

Treatment Guidelines

• Empiric therapy should be guided by local antimicrobial resistance patterns, covering Enterobacteriaceae and Enterococci in symptomatic patients, with first-line options including Nitrofurantoin, Trimethoprim-sulfamethoxazole (TMP-SMX), and Fosfomycin, pending culture results, as recommended by the Infectious Diseases Society of America (IDSA) guidelines 7, 8, 9, 6, 10, 11, 1
• Treatment duration of 7-14 days is recommended for most UTIs, with shorter courses (3-5 days) of antibiotic therapy possibly sufficient for uncomplicated cases in adults, according to the European Urology guidelines 7, 6, 1
• Fosfomycin trometamol is a convenient single-dose therapy option for UTIs, with a dosage of 3 g single dose and a duration of 1 day, as recommended by the European Urology guidelines 6
• Asymptomatic bacteriuria (positive urine culture without symptoms) should not be treated except in pregnant women and patients undergoing invasive urological procedures, as recommended by the European Association of Urology, the IDSA, and the American College of Physicians 10, 6, 12, 13
• The risk of progression to sepsis is very low in ASB, but higher in UTIs, especially in pyelonephritis, as shown in the following table:

Prevention and Follow-up

• Non-antimicrobial measures such as methenamine hippurate, immunoactive prophylaxis, probiotics, cranberry products, or D-mannose may be considered for preventing recurrent UTIs, with varying levels of recommendation from the European Association of Urology 6
• Repeat urinalysis should be performed 1-2 weeks after completing antibiotics to confirm resolution of abnormalities, according to the American Academy of Family Physicians and the American College of Physicians 14, 15
• If hematuria or proteinuria persists after treatment, refer for urologic evaluation including possible cystoscopy and upper tract imaging, as recommended by the American Academy of Family Physicians and the American College of Physicians 14, 15